About H2-Pharma
H2-Pharma is a company based in Montgomery (United States) founded in 2013 was acquired by ANI Pharmaceuticals in February 2016. H2-Pharma offers products and services including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products. H2-Pharma operates in a competitive market with competitors including AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
- Headquarter Montgomery, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name H2-Pharma, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
ANI Pharmaceuticals
& 1 more
-
Employee Count
Not available
-
Acquired by
ANI Pharmaceuticals
(Feb 01, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of H2-Pharma
H2-Pharma offers a comprehensive portfolio of products and services, including Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products.
Sales and distribution of branded medications for various health needs.
Affordable alternatives for branded drugs in the pharmaceutical market.
Distribution of non-prescription health products to customers.
Funding Insights of H2-Pharma
Investors in H2-Pharma
H2-Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ANI Pharmaceuticals and Ardian.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm specializing in markets and partnerships.
|
Locked | Locked | Locked | |
|
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
Locked | Locked | Locked |
Investor details for H2-Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by H2-Pharma
Investment portfolio details for H2-Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - H2-Pharma
Detailed financials for H2-Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
H2-Pharma Comparisons
Peer comparison for H2-Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of H2-Pharma
H2-Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by Renee in the United States.
|
Detailed competitors of H2-Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on H2-Pharma
Complete news archive for H2-Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about H2-Pharma
H2-Pharma was founded in 2013 and raised its 1st funding round 7 years after it was founded.
H2-Pharma is headquartered in Montgomery, United States. It is registered at Montgomery, Alabama, United States.
Brooke Cantey is the current CEO of H2-Pharma.
H2-Pharma was founded in 2013 and is headquartered in Montgomery, United States. Operations center on the distribution of generic pharmaceutical drugs within the healthcare sector. Supplies are provided to pharmacies, hospitals, and other providers across various markets. The company is led by Brooke Cantey, serving as CEO and President. Its online presence is maintained through the domain h2-pharma.com, supporting logistical and informational needs.
H2-Pharma's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
H2-Pharma offers Branded Pharmaceuticals, Generic Pharmaceuticals, and Non-Rx Products.
H2-Pharma has 2 investors. Key investors include ANI Pharmaceuticals, and Ardian.